Evidence map›Paper›PMID 41530509›Full record

ArticleScientific reports2026

The triglyceride HDL cholesterol ratio predicts sarcopenia risk in an aging National cohort from China.

Wei Ye, Shasha Chen, Diying Jiang, Yuan Wang, Xiaomeng Sun, Qiang Liu

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wei YeDepartment of Geriatrics, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Shasha ChenDepartment of Geriatrics, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Diying JiangDepartment of Geriatrics, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Yuan WangDepartment of Geriatrics, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Xiaomeng SunDepartment of Geriatrics, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Qiang LiuDepartment of Geriatrics, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. liuqianghare@zju.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to explore the association between the triglyceride/high-density lipoprotein cholesterol (TG/HDL-C) ratio and the odds of sarcopenia in elderly individuals in China. The study population comprised 2,481 participants aged 60 years or older from the China Health and Retirement Longitudinal Study (CHARLS). All participants were free of sarcopenia at baseline in 2011 and completed follow-up assessments in 2015. Multivariable logistic regression models were applied to examine the association between the TG/HDL-C ratio and incident sarcopenia. Subgroup, sensitivity, and post hoc power analyses were performed, and restricted cubic spline models were used to examine potential nonlinear associations. Compared with the lowest quartile (Q1), participants in Q3 and Q4 of TG/HDL-C ratio had significantly lower odds of incident sarcopenia (OR 0.34 [95% CI 0.20–0.55] for Q3; OR 0.55 [95% CI 0.36–0.84] for Q4). A consistent inverse association was observed when TG/HDL-C ratio was analyzed as a continuous variable (OR 0.83 [95% CI 0.74–0.93]). Subgroup analyses showed that the protective association was more pronounced in males. In Chinese older adults, a higher TG/HDL-C ratio is associated with reduced risk of developing sarcopenia, particularly among men.

Indexed as

AgingCholesterol, HDLSarcopeniaTriglyceridesAgedChinaFemaleHumansLongitudinal StudiesMaleMiddle AgedRisk FactorsCholesterol, HDLTriglyceridesChina health and retirement longitudinal study (CHARLS)SarcopeniaTriglyceride/high-density lipoprotein cholesterol ratio

Identifiers

PMID41530509
PMCPMC12876980

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.